BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 5158156)

  • 1. [Aggressive chronic hepatitis and non-alcoholic cirrhosis of moderate activity and immunosuppressive treatment].
    de Groote J; Fevery J; Vandenbroucke J
    Arch Fr Mal App Dig; 1971 Dec; 60(12):664-9. PubMed ID: 5158156
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis associated antigen in cases of banal and chronic hepatitis and in cases of cirrhosis.
    Demeulenaere M
    Arch Fr Mal App Dig; 1971 Dec; 60(12):670-2. PubMed ID: 5158157
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis B virus antigens in acute and chronic hepatitis and liver cirrhosis. Clinical, morphologic, enzymatic and immunologic analysis.
    Nazarewicz T; Milewski B; Krawczyński K; Nowoslawski A
    Mater Med Pol; 1975; 7(3):191-6. PubMed ID: 1177521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Australia antigen in chronic hepatitis].
    Petera V; Koza J
    Cesk Gastroenterol Vyz; 1971 Oct; 25(7):316-8. PubMed ID: 5000924
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of immune histological findings for indication of immunosuppressive therapy in chronic aggressive hepatitis].
    Storch W; Emmrich R; Petzold H
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:174-6. PubMed ID: 4580507
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoaggression and immunodepression in chronic hepatitis physiopathology.
    Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Boroş I; Moucha R; Jinga V; Gheorghe N; Metz L; Ciontescu L; Pintilescu V
    Rev Roum Physiol; 1974; 11(3):239-52. PubMed ID: 4842047
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Virus-like particles in HBsAg-positive-chronic aggressive hepatitis and liver cirrhosis.
    Yamada G; Tobe K; Kobayashi T; Ohta Y; Kosaka K
    Gastroenterology; 1976 Jan; 70(1):149. PubMed ID: 1245280
    [No Abstract]   [Full Text] [Related]  

  • 8. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavior of immunoglobulins in the immunosuppressive therapy of liver diseases].
    Bauch K; Zimmermann S; Lewicki I; Büttner W
    Dtsch Gesundheitsw; 1972 Nov; 27(45):2135-7. PubMed ID: 4650683
    [No Abstract]   [Full Text] [Related]  

  • 10. [Australia antigen in various liver diseases (except acute hepatitis). 3].
    Migneco G; Mansueto S; Tripi S
    G Mal Infett Parassit; 1971 Dec; 23(12):1125-6. PubMed ID: 5151318
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interpretation possibilities of the presence of Australia antigen (Au. an.) in patients with chronic hepatitis and hepatic cirrhosis].
    Turcu E; Efanov A; Macarie C
    Med Interna (Bucur); 1973 Sep; 25(9):1127-34. PubMed ID: 4209305
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between the presence of Australia antigen and some clinical and humoral features of various chronic liver diseases].
    Coltorti M; Del Vecchio-Blanco C; Oriani GA; Carrella M
    Minerva Med; 1972 Sep; 63(62):3367-75. PubMed ID: 4626800
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-term treatment of chronic aggressive hepatitis and liver cirrhosis using immunosuppressive agents].
    Bannaski H
    Med Welt; 1974 Sep; 25(39):1551-5. PubMed ID: 4427553
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunoglobulins and histological findings in chronic liver diseases treated with immunosuppressive agents].
    Bauch K; Büttner W; Lewicki I; Zimmermann S; Dempe A
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:169-72. PubMed ID: 4728086
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune complexes in viral hepatitis. Fulminating hepatitis].
    Guardia J; Martinez-Vazquez JM; Marsal J; Ferragut A; Bacardi R
    Nouv Presse Med; 1972 Jun; 1(26):1763-8. PubMed ID: 4626551
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term results of immunosuppressive treatment of chronic aggressive hepatitis (author's transl)].
    Gottesmann T; Moeschlin S
    Dtsch Med Wochenschr; 1978 Dec; 103(50):1989-93. PubMed ID: 720235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Australia-SH antigen isolation in patients with liver disease].
    Kaboth U; Schober A; Arndt HJ; Vido I; Creutzfeldt W
    Bibl Haematol; 1971; 37():245-50. PubMed ID: 5138911
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of cellular immunity using a skin test in chronic hepatitis and liver cirrhosis].
    Savorani G; Sarti G
    Boll Soc Ital Biol Sper; 1976 Jun; 52(12):859-65. PubMed ID: 1023897
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunoelectrophoretic analysis and study of Au SH antigens in patients with acute viral hepatitis, chronic hepatitis and liver cirrhosis].
    Kostic A; Bajic V; Cvoric M; Nikolic P
    Srp Arh Celok Lek; 1973 May; 101(5):311-21. PubMed ID: 4787444
    [No Abstract]   [Full Text] [Related]  

  • 20. The detection of hepatitis B antigen in hepatic parenchyma by the fluorescent antibody technic.
    Orr W
    Am J Clin Pathol; 1975 Aug; 64(2):257-62. PubMed ID: 50731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.